Eyepoint Pharmaceuticals Stock Market Value
| EYPT Stock | USD 7.17 0.48 6.27% |
| Symbol | Eyepoint |
Eyepoint Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyepoint Pharmaceuticals. If investors know Eyepoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyepoint Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.99) | Revenue Per Share | Quarterly Revenue Growth (0.31) | Return On Assets | Return On Equity |
The market value of Eyepoint Pharmaceuticals is measured differently than its book value, which is the value of Eyepoint that is recorded on the company's balance sheet. Investors also form their own opinion of Eyepoint Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eyepoint Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyepoint Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eyepoint Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eyepoint Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyepoint Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyepoint Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eyepoint Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eyepoint Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eyepoint Pharmaceuticals.
| 02/09/2024 |
| 02/03/2025 |
If you would invest 0.00 in Eyepoint Pharmaceuticals on February 9, 2024 and sell it all today you would earn a total of 0.00 from holding Eyepoint Pharmaceuticals or generate 0.0% return on investment in Eyepoint Pharmaceuticals over 360 days. Eyepoint Pharmaceuticals is related to or competes with Reviva Pharmaceuticals, Protalix Biotherapeutics, Sellas Life, Alpha Tau, HCW Biologics, Innate Pharma, and Orchestra BioMed. EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatm... More
Eyepoint Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eyepoint Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eyepoint Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 40.16 | |||
| Value At Risk | (7.23) | |||
| Potential Upside | 7.34 |
Eyepoint Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eyepoint Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eyepoint Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eyepoint Pharmaceuticals historical prices to predict the future Eyepoint Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | (44.29) |
Eyepoint Pharmaceuticals Backtested Returns
Eyepoint Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of risk over the last 3 months. Eyepoint Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eyepoint Pharmaceuticals' Standard Deviation of 6.01, mean deviation of 4.44, and Variance of 36.13 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0038, which means not very significant fluctuations relative to the market. As returns on the market increase, Eyepoint Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Eyepoint Pharmaceuticals is expected to be smaller as well. At this point, Eyepoint Pharmaceuticals has a negative expected return of -0.56%. Please make sure to confirm Eyepoint Pharmaceuticals' mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and daily balance of power , to decide if Eyepoint Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.05 |
Virtually no predictability
Eyepoint Pharmaceuticals has virtually no predictability. Overlapping area represents the amount of predictability between Eyepoint Pharmaceuticals time series from 9th of February 2024 to 7th of August 2024 and 7th of August 2024 to 3rd of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eyepoint Pharmaceuticals price movement. The serial correlation of 0.05 indicates that only as little as 5.0% of current Eyepoint Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.05 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 1.63 |
Eyepoint Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eyepoint Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eyepoint Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eyepoint Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eyepoint Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eyepoint Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eyepoint Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eyepoint Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eyepoint Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eyepoint Pharmaceuticals Lagged Returns
When evaluating Eyepoint Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eyepoint Pharmaceuticals stock have on its future price. Eyepoint Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eyepoint Pharmaceuticals autocorrelation shows the relationship between Eyepoint Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eyepoint Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Eyepoint Stock Analysis
When running Eyepoint Pharmaceuticals' price analysis, check to measure Eyepoint Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eyepoint Pharmaceuticals is operating at the current time. Most of Eyepoint Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eyepoint Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eyepoint Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eyepoint Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.